---
title: Albemarle (ALB) — intrinsic value and fair price
canonical: https://sweetvaluelab.com/stocks/alb
ticker: ALB
as_of: 2026-10-17
sector: Basic Materials
industry: Chemicals - Specialty
---
# Albemarle (ALB)

Albemarle (ALB) closed at $95.48 on Oct 16, 2026, overvalued by 17% vs its model value of $81.75 (from its peers' median EV/Revenue).

## Key figures

| Figure | Value |
| --- | ---: |
| Last close | $95.48 (Oct 16, 2026) |
| Model value (from its peers' median EV/Revenue) | $81.75 |
| Price vs model | overvalued by 17% vs model |
| Range of that model | $81.75 – $168.42 |
| Market value | $11.3B |
| P/E (fiscal 2025) | — |
| Net margin (fiscal 2025) | -9.9% |
| Free cash flow (fiscal 2025) | $692.5M |
| Dividend yield (trailing twelve months) | 1.70% |
| Beta | 1.36 |
| Cost of capital (WACC) | 9.10% |
| Business classification | Loss-Making (Revenue declining (~-27% recent), Currently unprofitable, Pays dividends, Highly cyclical earnings, Strong FCF yield (6.1%)) |

## On the stock lists

| List | Place | Figure | Page |
| --- | ---: | ---: | --- |
| Worst performing this year | #28 | −32.5% | https://sweetvaluelab.com/lists/worst-performing-this-year |
| Dividend growth streaks | #41 | 31+ years | https://sweetvaluelab.com/lists/dividend-growth-streaks |

## Dividends

| Figure | Value |
| --- | ---: |
| Trailing dividend yield | 1.70% |
| Dividends per share, last 12 months | $1.63 |
| Dividends / free cash flow (fiscal 2025) | 27.5% |
| Raised | 31+ years in a row |
| Growth over 5 years | 0.9% a year |
| Latest payment | $0.41, ex-date Sep 11, 2026, paid Oct 1, 2026 |

| Year of payments | Dividends per share |
| --- | ---: |
| To Sep 16, 2021 | $1.56 |
| To Sep 15, 2022 | $1.58 |
| To Sep 14, 2023 | $1.60 |
| To Sep 13, 2024 | $1.61 |
| To Sep 12, 2025 | $1.62 |
| Trailing twelve months (to Sep 11, 2026) | $1.63 |

## Valuation models

Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026.

| Model | Role | Value per share | Low | High |
| --- | --- | ---: | ---: | ---: |
| DCF · Perpetuity growth · 5y | primary | $0.00 | $0.00 | $0.00 |
| DCF · Perpetuity growth · 10y | cross check | $0.00 | $0.00 | $0.00 |
| DCF · EBITDA exit · 5y | cross check | $0.00 | $0.00 | $0.00 |
| DCF · EBITDA exit · 10y | cross check | $0.00 | $0.00 | $0.00 |
| EV/EBITDA · peers | cross check | $0.00 | $0.00 | $0.00 |
| EV/Revenue · peers | cross check | $81.75 | $0.00 | $168.42 |
| Earnings power value | cross check | $0.00 | $0.00 | $0.00 |
| Dividend discount | cross check | $0.00 | $0.00 | $0.00 |

## Insider activity (SEC Form 4)

No open-market insider buys or sales filed in the past 90 days.

| Date | Insider | Relationship | Transaction | Shares | Value |
| --- | --- | --- | --- | ---: | ---: |
| Oct 1, 2026 | Wolff Alejandro Daniel | Director | Grant / award | 45 | $0 |
| Sep 14, 2026 | Norris Eric | Chief Commercial Officer | Grant / award | 10,867 | $0 |
| Sep 14, 2026 | Mummert Mark Richard | Chief Operations Officer | Grant / award | 6,086 | $0 |
| Sep 14, 2026 | Gagarinas Autumn M. | Chief People Officer | Grant / award | 5,217 | $0 |
| Sep 1, 2026 | Hood Max | Chief Accounting Officer | Grant / award | 1,476 | $0 |

## Recent SEC filings

| Filed | Form | What | Filing |
| --- | --- | --- | --- |
| Sep 3, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/915913/000114036126035623/ef20081522_8k.htm |
| Aug 21, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers | https://www.sec.gov/Archives/edgar/data/915913/000091591326000107/alb-20260819.htm |
| Aug 5, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/915913/000091591326000102/alb-20260630.htm |
| Aug 5, 2026 | 8-K | 2.02 Results of Operations (Earnings); 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/915913/000091591326000101/alb-20260805.htm |
| Jul 23, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/915913/000091591326000095/alb-20260721.htm |

## Superinvestors holding it (latest 13F)

| Manager | Quarter | Shares | Value |
| --- | --- | ---: | ---: |
| Bridgewater | 2026-06-30 | 116,250 | $15.7M |

1 tracked managers in all.

## About

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as ai…

---

Source: https://sweetvaluelab.com/stocks/alb (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.